| Expression pattern: |
UP |
| Associated gene: |
MDM2 |
| Associated microRNA: |
miR-29c-3p |
| Biological function: |
hsa_circ_0001020 accelerates DVT formation and inhibits EPC migration, invasion, angiogenesis, and tube formation; hsa_circ_0001020 knockdown suppresses thrombosis and promotes EPC homing into thrombi. |
| Molecular mechanism: |
hsa_circ_0001020 functions as a ceRNA sponge for miR-29c-3p, thereby promoting MDM2 expression and inhibiting EPC migration, invasion, and angiogenesis in DVT. |
| Biological pathway or process: |
ceRNA regulation (other); migration (inhibits); invasion (inhibits); angiogenesis (inhibits); other pathway/process (promotes) |
| Detected method: |
Q
H
M
|
| Validation methods: |
Microarray; RT-qPCR; Clinical Sample Validation; RNase R Treatment; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; Wound Healing Assay; Transwell Assay; Tube Formation Assay; Western Blot; IF (Immunofluorescence); In Vivo Animal Model; H&E Staining; Bioinformatics Analysis |
| Clinical significance: |
hsa_circ_0001020 might be a potential therapeutic target and biomarker for DVT. |
| Description: |
hsa_circ_0001020 is up-regulated in peripheral blood from DVT patients and is mainly localized in the cytoplasm of EPCs. It promotes DVT progression by sponging miR-29c-3p to increase MDM2 expression, thereby inhibiting EPC migration, invasion, angiogenesis, and thrombus-resolution-related homing. Knockdown of hsa_circ_0001020 suppresses thrombosis in a DVT mouse model, suggesting therapeutic potential. |
| Confidence score: |
0.8108 |